Literature DB >> 17541533

[Indications for an implantable cardioverter/defibrillator].

J O Schwab1, B Lüderitz.   

Abstract

The implantable cardioverter/defibrillator (ICD), which uses antitachycardia pacing or shock, is the only adequate therapeutic option for life threatening ventricular tachyarrhythmias. The results of prospective, randomised ICD trials show that the indications for primary and secondary prevention of sudden cardiac death have changed in a relevant manner. After the identification of a patient at risk, the implantation of an ICD reduces cardiac and total mortality significantly. A clear diagnostic procedure and the parameters needed for the identification of this risk are essential. We report on the indications for the implantation of an ICD following current guidelines in order to enable the physician to provide his patients with an adequate ICD therapy in everyday practice.

Entities:  

Mesh:

Year:  2007        PMID: 17541533     DOI: 10.1007/s00108-007-1871-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  15 in total

1.  MADIT-II: substudies and their implications.

Authors:  Arthur J Moss
Journal:  Card Electrophysiol Rev       Date:  2003-12

Review 2.  [Position paper on "automated external defibrillation" ].

Authors:  H-J Trappe; D Andresen; H-R Arntz; H-J Becker; K Werdan
Journal:  Z Kardiol       Date:  2005-04

3.  [Guidelines for the implantation of defibrillators].

Authors:  W Jung; D Andresen; M Block; D Böcker; S H Hohnloser; K-H Kuck; J Sperzel
Journal:  Clin Res Cardiol       Date:  2006-12       Impact factor: 5.460

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol.

Authors:  S H Hohnloser; S J Connolly; K H Kuck; P Dorian; E Fain; J R Hampton; R Hatala; A C Pauly; R S Roberts; E Themeles; M Gent
Journal:  Am Heart J       Date:  2000-11       Impact factor: 4.749

7.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

8.  Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.

Authors:  M S Wathen; M O Sweeney; P J DeGroot; A J Stark; J L Koehler; M B Chisner; C Machado; W O Adkisson
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

9.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.

Authors:  Bruce L Wilkoff; Kevin T Ousdigian; Laurence D Sterns; Zengri J Wang; Ryan D Wilson; John M Morgan
Journal:  J Am Coll Cardiol       Date:  2006-06-22       Impact factor: 24.094

10.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.